Normal component of TMS-induced electric field is correlated with depressive symptom relief in treatment-resistant depression

202302 bcwwVersion of RecordRGCOthersAustrian Science Fund (FWF) [grant number KLI 551, PI: S. Kasper]General Research Fund (GRF) under the University Grants Committee (UGC) of the Hong Kong Special Administrative Region [grant numbers 15100120 and 25100219, PI: G.S. Kranz]Publishe

The impact of theta-burst stimulation on cortical GABA and glutamate in treatment-resistant depression : a surface-based MRSI analysis approach

202309 bcvcVersion of RecordOthersLundbeck; Siemens HealthcarePublishe

Effects of bilateral sequential theta-burst stimulation on functional connectivity in treatment-resistant depression : first results

202310 bcvcVersion of RecordOthersAustrian Science FundPublishe

Amiloidose localizada laríngea: relato de caso e revisão de literatura Localized laryngeal amyloidosis: case report and literature review

A amiloidose localizada laríngea é uma doença rara, correspondendo a menos de 1% dos tumores benignos da laringe. No entanto, a amiloidose localizada acomete principalmente a laringe nas vias aéreas, sendo assim de grande importância para o otorrinolaringologista. Ela está relacionada à produção monoclonal de imunoglobulinas de cadeia leve, principalmente l e k. Este estudo tem como objetivo relatar um caso de amiloidose laríngea atendida no Ambulatório de Laringologia e Voz do Hospital das Clínicas da FMRP - USP, assim como discutir a revisão de literatura.<br>Localized laryngeal amyloidosis is a rare disease, corresponding to less than 1% of benign tumors in larynx. However, localized amyloidosis occurs mostly in larynx, being of great importance its diagnose by Otorhinolaryngologists. It is related to monoclonal production of light chain immunoglobulins, mainly l and k. This study has the purpose of relating a case of laryngeal amyloidosis assisted in Laryngology and Voice Clinics at Clinics Hospital FMRP - USP, and discussing literature as well

Parcellation of the human cerebral cortex based on molecular targets in the serotonin system quantified by positron emission tomography in vivo

201901 bcmaVersion of RecordRGC25100219Publishe